Inoviq (ASX:IIQ) Days Payable : 6,510.96 (As of Dec. 2023)

View and export this data going back to 1991. Start your Free Trial

What is Inoviq Days Payable?

Inoviq's average Accounts Payable for the six months ended in Dec. 2023 was A$0.61 Mil. Inoviq's Cost of Goods Sold for the six months ended in Dec. 2023 was A$0.02 Mil. Hence, Inoviq's Days Payable for the six months ended in Dec. 2023 was 6,510.96.

The historical rank and industry rank for Inoviq's Days Payable or its related term are showing as below:

ASX:IIQ' s Days Payable Range Over the Past 10 Years
Min: 4003.59 Med: 5202.85 Max: 10047.11
Current: 10047.11

During the past 13 years, Inoviq's highest Days Payable was 10047.11. The lowest was 4003.59. And the median was 5202.85.

ASX:IIQ's Days Payable is ranked better than
99.03% of 206 companies
in the Medical Diagnostics & Research industry
Industry Median: 68.79 vs ASX:IIQ: 10047.11

Inoviq's Days Payable declined from Dec. 2022 (11,197.14) to Dec. 2023 (6,510.96). It may suggest that Inoviq accelerated paying its suppliers.

Inoviq Days Payable Historical Data

The historical data trend for Inoviq's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inoviq Days Payable Chart

Inoviq Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Days Payable

Get a 7-Day Free Trial

4,003.59

5,202.85

6,167.67

Inoviq Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial															6,205.00	3,428.72	11,197.14	10,393.81	6,510.96

Competitive Comparison of Inoviq's Days Payable

For the Diagnostics & Research subindustry, Inoviq's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Inoviq's Days Payable Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Inoviq's Days Payable distribution charts can be found below:

* The bar in red indicates where Inoviq's Days Payable falls into.

Inoviq Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Inoviq's Days Payable for the fiscal year that ended in Jun. 2023 is calculated as

	Days Payable (A: Jun. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Jun. 2022 )	+	Accounts Payable (A: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (A: Jun. 2023 )	*	Days in Period
=	( (1.02	+	0.467)	/	2 )	/	0.044	*	365
=	0.7435					/	0.044	*	365
=	6,167.67

Inoviq's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (0.467	+	0.746)	/	2 )	/	0.017	*	365 / 2
=	0.6065					/	0.017	*	365 / 2
=	6,510.96

Inoviq Days Payable Related Terms

Thank you for viewing the detailed overview of Inoviq's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Inoviq (ASX:IIQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Inoviq Ltd (ASX:IIQ) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

23 Normanby Road, Notting Hill, Melbourne, VIC, AUS, 3168

Website

https://www.bard1.com

Inoviq Ltd is engaged in developing and commercializing a portfolio of diagnostic and exosome-based products to improve the diagnosis and treatment of cancer and other diseases. The company has commercialized the hTERT test used as an adjunct to urine cytology testing for bladder cancer and the EXO-NET pan-exosome capture tool for research purposes. Its cancer diagnostic pipeline includes blood tests in development for earlier detection and monitoring of ovarian, breast, prostate, and other cancers.

Inoviq (ASX:IIQ) Headlines

No Headlines